Purchase Order 75D30123P18088
- Not listed
- This federal contract award, valued at $63,189.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for the provision of BIO RAD SUPPLIES and has a completion date of September 30, 2023. No set-aside designation was used. Bio-Rad Laboratories, Inc. is an experienced federal contractor, holding several significant...
- This $95,000.00 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Bio-Rad Laboratories, Inc. Life Science Group Division for LABORATORY SUPPLIES. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics equipment, reagents, and consumables. It has established relationships with multiple federal agencies, including the CDC, through prime contract...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,742.00 firm fixed-price purchase order contract to Bio-Rad Laboratories, Inc. Life Science Group Division for the provision of laboratory supplies. The contract has an ultimate completion date of September 21, 2024. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products. As the parent company, Bio-Rad Laboratories, Inc. holds several significant federal Indefinite Delivery...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Bio-Rad Laboratories, Inc., a global leader in developing and manufacturing products for life science research and clinical diagnostics. The $88,935.00 contract is for the provision of Bio-Rad reagents, with an ultimate completion date of September 25, 2020. The contract was a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Bio-Rad Laboratories, Inc. has established several...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $52,451.52 by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, with performance executed at the company's manufacturing facility in Hercules, California. The contract was awarded on September 3, 2021, with an ultimate completion date of September 2, 2024. No small business set-aside designation was applied to this award, consistent with Bio-Rad's status as an established large federal...
- This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Bio-Rad Laboratories, Inc. Life Science Group Division, a for-profit manufacturer of biotechnology products and laboratory equipment. The $103,398.60 firm-fixed-price purchase order is for the delivery of a DDPCR SYSTEM. No set-aside designation was indicated. Bio-Rad Laboratories holds a 5-year, $1 billion blanket purchase agreement with the National Institutes of...
- The Centers for Disease Control and Prevention (CDC) awarded a $22,944.00 firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. for PCR system equipment maintenance. The contract has an ultimate completion date of April 22, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics, and serves as a prime contractor to numerous federal agencies, including the National Institutes of Health (NIH),...
- This federal contract award is for the QX600 SYSTEN, a product provided by Bio-Rad Laboratories, Inc. Life Science Group Division. The award, valued at $95,000.00, is a firm fixed-price purchase order placed by the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The contract has no set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing life science research and clinical diagnostics products. The company holds a major $1 billion...
- Bio-Rad Laboratories Inc. was awarded a $33,000 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) Pittsburgh on August 14, 2024, for FDA-approved test kits, readers, and laptops designed to strengthen rapid test quality assurance internationally. The contract, which carries an ultimate completion date of April 22, 2025, represents an unrestricted procurement with no small business set-aside designation. Performance will be executed at Bio-Rad's Hercules,...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., is for the provision of pathogen detection kits and instruments. The $76,656.82 firm fixed-price delivery order was awarded by the Civilian agency Office of Administrative Services Procurement Management Branch. This contract is not associated with a set-aside designation. Bio-Rad Laboratories, Inc. holds several significant Indefinite Delivery Vehicles (IDVs) and...
This federal contract award is for a BIO-RAD 200 SYSTEM with a ceiling value of $62,720.00. The contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, a civilian agency, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is a Firm Fixed Price Purchase Order with a completion date of September 24, 2024. No set-aside was used for this award. Bio-Rad Laboratories, Inc. is a leading manufacturer and supplier of specialized products for life science research and clinical diagnostics. The company has established relationships with multiple government agencies, particularly in the health and research sectors, through prime federal contract awards. Bio-Rad holds several significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with federal agencies, including a $1 billion BPA with the National Institutes of Health (NIH) for the procurement of biological materials, laboratory supplies, and other items.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.7k | 9/18/23 |